NLM Logo

NEO-MACOP-B protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
NEO-MACOP-B protocol
Unique ID
C084218
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C084218
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Cyclophosphamide
Doxorubicin
Etoposide
Methotrexate
Mitoxantrone
Prednisolone
Vincristine
Frequency
1
Note
a chemotherapy protocol which includes etoposide and mitoxantrone in addition to MACOP-B with half dose of methotrexate and half administration of doxorubicin; used for the treatment of advanced stage aggressive non-Hodgkin's lymphoma; reduces severe mucositis, a major toxic effect of MACOP-B
Source
Gan To Kagaku Ryoho 1993 Nov;20(14):2183-9
Date of Entry
1993/12/14
Revision Date
2000/11/30
NEO-MACOP-B protocol Preferred
page delivered in 0.005s